Drugs / Glycophos Injectable Product
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT06651892 Comparator | May → Dec 2024 | hypophosphatemia | Ain Shams University | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycophos Injectable Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06651892 ↗ |
| Route | Intravenous | “intravenous sodium glycerophosphate” NCT06651892 ↗ |